Document Detail

CD30-positive anaplastic large cell T-cell lymphoma developing during immunosuppressive therapy of pityriasis rubra pilaris with ustekinumab.
MedLine Citation:
PMID:  23322178     Owner:  NLM     Status:  Publisher    
The development of malignancies during therapy with biologics has been discussed controversially. A patient with extensive pityriasis rubra pilaris failed to respond to standard therapeutic approaches. While receiving immunomodulatory therapy, lastly with ustekinumab, the patient developed a CD30(+) anaplastic large cell lymphoma.
D Humme; M Beyer; H-J Röwert-Huber; W Sterry; S Philipp
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-17
Journal Detail:
Title:  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete     Volume:  -     ISSN:  1432-1173     ISO Abbreviation:  Hautarzt     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372755     Medline TA:  Hautarzt     Country:  -    
Other Details:
Languages:  GER     Pagination:  -     Citation Subset:  -    
Klinik für Dermatologie, Venerologie und Allergologie, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland,
Vernacular Title:
CD30-positives anaplastisch großzelliges T-Zell-Lymphom unter immunsuppressiver Therapie einer Pityriasis rubra pilaris mit Ustekinumab.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nitric oxide (NO) counteracts cadmium induced cytotoxic processes mediated by reactive oxygen specie...
Next Document:  Extracorporeal shock wave therapy as a treatment of a non-healing chronic leg ulcer.